Zobrazeno 1 - 10
of 1 018
pro vyhledávání: '"1115 Pharmacology and Pharmaceutical Sciences"'
Publikováno v:
Current Drug Delivery. 20:1031-1036
Abstract: Nanomedicines have been used over time because of their significant impact on human health care for the prevention, early detection, diagnosis, treatment, and follow-up of a wide range of illnesses. Nanomedicines must be adequately characte
Publikováno v:
Infection and Drug Resistance. 16:2709-2726
Bacterial and fungal infections are common issues for patients in the intensive care unit (ICU). Large, multinational point prevalence surveys have identified that up to 50% of ICU patients have a diagnosis of bacterial or fungal infection at any one
Autor:
Asif Ahmad Bhat, Riya Thapa, Ahsas Goyal, Vetriselvan Subramaniyan, Deepak Kumar, Saurabh Gupta, Sachin Kumar Singh, Kamal Dua, Gaurav Gupta
Publikováno v:
Future Medicinal Chemistry. 15:583-586
Impact of Smoking Status and Nicotine Dependence on Academic Performance of Health Sciences Students
Autor:
Jaber S Alqahtani, Abdulelah M Aldhahir, Zaid Alanazi, Emad Zahi Alsulami, Mujahid A Alsulaimani, Abdullah A Alqarni, Abdullah S Alqahtani, Ayadh Yahya AlAyadi, Musallam Alnasser, Ibrahim A AlDraiwiesh, Saeed M Alghamdi, Hussam M Almarkhan, Abdullah S Alsulayyim, Saad M AlRabeeah, Mohammed D AlAhmari
Publikováno v:
Substance Abuse and Rehabilitation. 14:13-24
Jaber S Alqahtani,1 Abdulelah M Aldhahir,2 Zaid Alanazi,3 Emad Zahi Alsulami,4 Mujahid A Alsulaimani,5 Abdullah A Alqarni,6 Abdullah S Alqahtani,1 Ayadh Yahya AlAyadi,1 Musallam Alnasser,1 Ibrahim A AlDraiwiesh,1 Saeed M Alghamdi,7 Hussam M Almarkhan
Autor:
Kamal Dua, Deepak Kumar, Monu K. Shukla, Amit Dubey, Sadanand Pandey, Sachin K. Singh, Gaurav Gupta, Parteek Prasher, Dinesh K. Chellappan, Brian G. Oliver
Publikováno v:
Current Pharmaceutical Design. 28:3202-3211
Abstract: Several factors exist that limit the efficacy of lung cancer treatment. These may be tumor-specific delivery of therapeutics, airway geometry, humidity, clearance mechanisms, presence of lung diseases, and therapy against tumor cell resista
Autor:
Indran Mathavan, Lawrence J. Liu, Sean W. Robinson, Nelly El-Sakkary, Adam Jo J. Elatico, Darwin Gomez, Ricky Nellas, Raymond J. Owens, William Zuercher, Iva Navratilova, Conor R. Caffrey, Konstantinos Beis
Publikováno v:
ACS Medicinal Chemistry Letters. 13:1715-1722
Schistosomiasis is a neglected tropical disease caused by parasitic flatworms. Current treatment relies on just one partially effective drug, praziquantel (PZQ). Schistosoma mansoni Venus Kinase Receptors 1 and 2 (SmVKR1 and SmVKR2) are important for
Autor:
Kumbhar, P, Kole, K, Khadake, V, Marale, P, Manjappa, A, Nadaf, S, Jadhav, R, Patil, A, Singh, SK, Dua, K, Jha, NK, Disouza, J, Patravale, V
Publikováno v:
Journal of Controlled Release. 349:812-830
Breast cancer (BC) is a highly diagnosed and topmost cause of death in females worldwide. Drug repurposing (DR) has shown great potential against BC by overcoming major shortcomings of approved anticancer therapeutics. However, poor physicochemical p
Autor:
Shaik Mohamed Sayed, UF, Moshawih, S, Goh, HP, Kifli, N, Gupta, G, Singh, SK, Chellappan, DK, Dua, K, Hermansyah, A, Ser, HL, Ming, LC, Goh, BH
Obesity affects more than 10% of the adult population globally. Despite the introduction of diverse medications aimed at combating fat accumulation and obesity, a significant number of these pharmaceutical interventions are linked to substantial occu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______363::f16fbd94bc754cf5622a5eac57a8d6ab
https://hdl.handle.net/10453/170829
https://hdl.handle.net/10453/170829
Lung cancer (LC) is the leading cause of cancer-related deaths globally. It accounts for more than 1.9 million cases each year due to its complex and poorly understood molecular mechanisms that result in unregulated cell proliferation and metastasis.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______363::c43765902161ca34fbd078e976f082e4
https://hdl.handle.net/10453/170599
https://hdl.handle.net/10453/170599
Autor:
Suman Saurabh, Cavan Kalonia, Zongyi Li, Peter Hollowell, Thomas Waigh, Peixun Li, John Webster, John M. Seddon, Jian R. Lu, Fernando Bresme
Publikováno v:
Molecular Pharmaceutics. 19:3288-3303
Histidine, a widely used buffer in monoclonal antibody (mAb) formulations, is known to reduce antibody aggregation. While experimental studies suggest a nonelectrostatic, nonstructural (relating to secondary structure preservation) origin of the phen